Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Progyny, Inc. Director's Dealing 2021

Jun 24, 2021

31752_dirs_2021-06-23_152cc4c7-43ef-4a4a-a561-9ebeceb0ce8e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Progyny, Inc. (PGNY)
CIK: 0001551306
Period of Report: 2021-06-21

Reporting Person: Livingston Mark S. (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-21 Common Stock M 2814 $23.16 Acquired 19935 Direct
2021-06-21 Common Stock M 41250 $3.95 Acquired 61185 Direct
2021-06-21 Common Stock F 1905 $63.15 Disposed 59280 Direct
2021-06-21 Common Stock F 20404 $63.18 Disposed 38876 Direct
2021-06-21 Common Stock S 22021 $62.33 Disposed 16855 Direct
2021-06-21 Common Stock S 1200 $63.61 Disposed 15655 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-21 Employee Stock Option (right to buy) $23.16 M 2814 Disposed 2030-03-08 Common Stock (2814) Direct
2021-06-21 Employee Stock Option (right to buy) $3.95 M 41250 Disposed 2029-06-23 Common Stock (41250) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.65 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: 25% of the shares subject to the Option vest on March 9, 2021, with the remaining shares vesting in equal quarterly installments thereafter through March 9, 2024, subject to the Reporting Person continuing to provide service through each such date.

F4: 25% of the shares subject to the Option vested on May 29, 2020, with the remaining shares vesting in equal monthly installments thereafter through May 29, 2023, subject to the Reporting Person continuing to provide service through each such date.